Company 1 identity field
Location
Silver Spring, MD
SEC filing record 1 source field
Fiscal year end
31 December
UNITED THERAPEUTICS Corp has filed 4,226 SEC EDGAR filings since 16 Apr 1999

SEC filing history

Showing 251-275 of 1,000 matching filings.

Per page
25
Current page
11
4

PRIMARY DOCUMENT

Filing date
18 Nov 2025
Reporting date
14 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
18 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
17 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
12 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Nov 2025
Reporting date
13 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
13 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Nov 2025
Reporting date
10 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
12 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
10 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Nov 2025
Reporting date
06 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
07 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Nov 2025
Reporting date
04 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
06 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
05 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
05 Nov 2025
Reporting date
04 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Nov 2025
Reporting date
31 Oct 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
04 Nov 2025
Reporting date
03 Nov 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
04 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
04 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
144 File 000-26301

144 filing

Filing date
03 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .